American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Open accessThe DOI matches its Crossref record; 166 of the 171 references it cites were found in a registry or an index.
Abstract
Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effective?7. What are the optimal strategies for transition to outpatient care? 8. What are areas for future research? QUESTION 1: DOES IMPROVING GLYCEMIC CONTROL IMPROVE CLINICAL OUTCOMES FOR INPATIENTS WITHHYPERGLYCEMIA? -Hyperglycemia in hospitalized patients, irrespective of its cause, is unequivocally associated with adverse outcomes (5,6,18 -25).Hyperglycemia occurs in patients with known or undiagnosed diabetes, or it occurs during acute illness in those with previously normal glucose tolerance (termed "stress hyperglycemia") (8,26).Intervention directed at reducing blood glucose (BG) levels has resulted in improved outcomes in some, but not all, studies (5,18 -25).Several recent clinical trials in critically ill patients have reported no reduction in mortality from intensive treatment targeting near-euglycemia versus conventional management targeting BG Ͻ180 mg/dl (Ͻ10.0 mmol/l).Of considerable concern are reports of harm, with higher rates of severe hypoglycemia and even increased mortality (14) resulting from intensive glycemic control (12)(13)(14)16,27,28).This variability in results may be attributable to several factors, including differences in intravenous (IV) insulin treatment protocols and their implementation, glycemic targets, patient populations, methods for glucose monitoring, and insulin adjustment (12,29).The following section focuses primarily on results of recent studies with an RCT design that investigated patient outcomes with protocols targeting nearnormalization of BG levels.Readers are referred to a previous ACE position statement (9), an ACE/ADA consensus statement (11), and a technical review (8) for details related to earlier studies supporting inpatient glycemic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [103]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Glucose targets >180 mg/dL or <110 mg/dL are no longer recommended in ICU patients.”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“and the BG targets used in this study were lower than glycemic targets recently recommended by the AACE and ADA inpatient glycemic control task force.25”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“Many guidelines that apply to hospitalized adults with hyperglycemia can probably be extrapolated to older adults130, 131.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Nevertheless, recent attempts to achieve tight glycemic control either have not reduced or have actually increased mortality in multicenter trials and clearly led to higher rates of hypoglycemia (13,14,16).”
BackgroundInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 5×
“The higher rates of severe hypoglycemia associated with intensive insulin therapy (12–14,16,27,28) raise the possibility that serious adverse events in the subgroup of patients experiencing hypoglycemia offset, at least in part, any benefit derived from strict glycemic control in the much larger subgroup of patients w…”
BackgroundInfluentialHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., & Bates, D. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00007 · Cited by 1,886 · cited 1×
“Medication errors and adverse drug events have been linked to poor communication of instructions to the patient at the time of discharge (156,157).”
Background
Research works printed but not linked: 5
- 28. Devos P, Preiser JC, Me ´lot C, et al. Im- pact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study (Abstract). Intensive Care Med 2007;33:S189
- 87. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1):1-68
- 93. DiNardo M, Donihi AC, DeVita M, et al. A nurse directed protocol for recogni- tion and treatment of hypoglycemia in hospitalized patients. Pract Diabetol 2005;22:37-40
- 97. Donihi AC, Rea RS, Mihalko MA, et al. Comparison of different methods of transitioning MICU patients from intra- venous to subcutaneous insulin (Ab- stract). Diabetes 2007;57:A542
- 117. Reider J, Lin H, Dinardo M, et al. Efficacy of a guideline for treatment of corticoste- roid related hyperglycemia in the hospi- tal (Abstract). Diabetes 2008;57:A574 120.
Cited by
Items 101–200 of 1,001
Brodovicz, K. G., Mehta, V., Zhang, Q., Zhao, C., Davies, M. J., Chen, J., Radican, L., & Engel, S. S. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.754744 · Cited by 112
Hsia, E., Seggelke, S., Gibbs, J., Hawkins, R. M., Cohlmia, E., Rasouli, N., Wang, C., Kam, I., & Draznin, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1244 · Cited by 112
Resende, V. A. C., Neto, A. C., Nunes, C., Andrade, R., Espregueira‐Mendes, J., & Lopes, S. (2018) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-018-5231-9 · Cited by 110
14. Diabetes Care in the Hospital
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc17-s017 · Cited by 110
Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review
Bonaventura, A., & Montecucco, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.006 · Cited by 108
Dainiak, N., Gent, R. N., Carr, Z. A., Schneider, R., Bader, J. L., Buglova, E. E., Chao, N. J. A., Coleman, C. N., Ganser, A., Gorin, N. C., et al. (2011) · Disaster Medicine and Public Health Preparedness · doi:10.1001/dmp.2011.73 · Cited by 107
Sathya, B., Davis, R., Taveira, T., Whitlatch, H., & Wu, W.-C. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.05.003 · Cited by 99
“moderate perioperative glycemic target of <180 mg/dL [4,5,19], although the BG target of <180 mg/dL is highly debatable.”
BackgroundInfluentialOlveira, G., Tapia, M. J., Ocón, J., Cabrejas-Gómez, C., Ballesteros-Pomar, M. D., Vidal-Casariego, A., Arraiza-Irigoyen, C., Olivares, J., Conde-García, M. D. C., García-Manzanares, Á., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1379 · Cited by 97
Baldwin, D., Zander, J., Munoz, C., Raghu, P., DeLange-Hudec, S., Lee, H., Emanuele, M. A., Glossop, V., Smallwood, K., & Molitch, M. (2012) · Diabetes Care · doi:10.2337/dc12-0578 · Cited by 103
13. Diabetes Care in the Hospital
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s016 · Cited by 104
Pretty, C. G., Compte, A. J. L., Chase, J. G., Shaw, G. M., Preiser, J., Penning, S., & Desaive, T. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-17 · Cited by 99
“8-11 mmol/L [38-40] is most appropriate for the first 24 hours with the target range, reducing over days 2 and 3 to more normoglycemic levels as SI level and variability improve.”
BackgroundPerioperative management of hyperglycemia and diabetes in cardiac surgery patients
Galindo, R. J., Fayfman, M., & Umpierrez, G. E. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.005 · Cited by 95
Self-citationA Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic
Korytkowski, M., Antinori-Lent, K., Drincic, A., Hirsch, I. B., McDonnell, M. E., Rushakoff, R., & Muniyappa, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa342 · Cited by 89
“19 initiated for patients with persistent BG > 180 mg/dl according to hospital or published guidelines (5,6) (Table 2).”
BackgroundInfluentialSelf-citationSardu, C., Paolisso, P., Sacra, C., Santamaria, M., de Lucia, C., Ruocco, A., Mauro, C., Paolisso, G., Rizzo, M. R., Barbieri, M., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0778-9 · Cited by 93
A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials
Spanakis, E. K., Cook, C. B., Kulasa, K. M., Aloi, J., Bally, L., Davis, G. M., Dungan, K. M., Galindo, R. J., Mendez, C. E., Pasquel, F. J., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231191104 · Cited by 92
Self-citationWeight-Based, Insulin Dose–Related Hypoglycemia in Hospitalized Patients With Diabetes
Rubin, D. J., Rybin, D., Doros, G., & McDonnell, M. E. (2011) · Diabetes Care · doi:10.2337/dc10-2434 · Cited by 84
“Given that insulin is recommended for most hospitalized patients with diabetes (4), and hypoglycemia is associated with increased length of stay andmortality (15), strategies to reduce hypoglycemia are of critical importance.”
BackgroundGlucose Control in the ICU: A Continuing Story
Preiser, J., Chase, J. G., Hovorka, R., Joseph, J. I., Krinsley, J. S., Block, C. E. M. D., Desaive, T., Foubert, L. A., Kalfon, P., Pielmeier, U., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816648713 · Cited by 88
Epigenetic modification and therapeutic targets of diabetes mellitus
Singh, R., Chandel, S., Dey, D., Ghosh, A., Roy, S., Ravichandiran, V., & Ghosh, D. (2020) · Bioscience Reports · doi:10.1042/bsr20202160 · Cited by 88
Hypoglycemia in Hospitalized Patients Treated with Sulfonylureas
Deusenberry, C. M., Coley, K. C., Korytkowski, M. T., & Donihi, A. C. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.2011.01088.x · Cited by 86
Self-citationFayfman, M., Galindo, R. J., Rubin, D. J., Mize, D. L., Anzola, I., Urrutia, M. A., Ramos, C., Pasquel, F. J., Haw, J. S., Vellanki, P., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1760 · Cited by 85
Self-citationEuropean Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke
Fuentes, B., Ntaios, G., Putaala, J., Thomas, B. M., Turc, G., & Díez‐Tejedor, E. (2017) · European Stroke Journal · doi:10.1177/2396987317742065 · Cited by 85
“0mmol/L (141–180mg/dL), avoiding more intensive targets that can result in a higher risk of hypoglycaemia.(19,51) There is also a general recommendation against the use of SC sliding-scale insulin or the so-called correction insulin based on the use of rapid-acting insulin in critically ill patients as the sole regime…”
BackgroundNewton, C. A., Smiley, D., Bode, B. W., Kitabchi, A. E., Davidson, P. C., Jacobs, S., Steed, R. D., Stentz, F., Peng, L., Mulligan, P., et al. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.816 · Cited by 84
Self-citationRajan, N., Duggan, E. W., Abdelmalak, B., Butz, S. F., Rodriguez, L. V., Vann, M. A., & Joshi, G. P. (2024) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006791 · Cited by 85
Diabetic ketoacidosis and COVID-19: what have we learned so far?
de Sá-Ferreira, C. O., da Costa, C. H. M., Guimarães, J. C. W., Sampaio, N. S., Silva, L. D. M. L., de Mascarenhas, L. P., Rodrigues, N. G., Santos, T. L., Campos, S., & Young, E. C. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00244.2021 · Cited by 83
“Hyperglycemia increases the risk of infections, alters the function of leukocytes, prolongs hospital stay, increases the virulence of some pathogens, and also increases the risk of cardiac arrhythmias and the mortality rate (38, 39).”
BackgroundKang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 85
Approach to the Patient with New-Onset Diabetes after Transplant (NODAT)
Lane, J. T., & Dagogo-Jack, S. E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0657 · Cited by 83
“0 mmol/liter)], may be used as a guide, given the lack of specific data for posttransplant patients (48).”
MethodThe Effect of Diabetes on Hospital Readmissions
Dungan, K. M. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600508 · Cited by 82
Greco, G., Ferket, B. S., D’Alessandro, D. A., Shi, W., Horvath, K. A., Rosen, A., Welsh, S., Bagiella, E., Neill, A. E., Williams, D. L., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1817 · Cited by 82
“operative and critical care settings, recommending that patients, regardless of their diabetes status, have their serum glucose levels maintained at,180mg/dL (6,13).”
BackgroundLevy, N., & Dhatariya, K. (2019) · Anaesthesia · doi:10.1111/anae.14510 · Cited by 81
Vellanki, P., Rasouli, N., Baldwin, D., Alexanian, S., Anzola, I., Urrutia, M., Cardona, S., Peng, L., Pasquel, F. J., Umpierrez, G. E., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13587 · Cited by 80
“Professional guidelines recommend the use of a basal-bolus insulin regimen for management of hyperglycaemia in hospitalized patients with T2D.13,26 Three studies have shown that treatment with a DPP-4 inhibitor alone or in combination with basal insulin resulted in glycaemic efficacy similar to that with a basal-bolus…”
ResultInfluentialSelf-citationStress hyperglycemia in general surgery: Why should we care?
Davis, G., Fayfman, M., Reyes-Umpierrez, D., Hafeez, S., Pasquel, F. J., Vellanki, P., Haw, J. S., Peng, L., Jacobs, S., & Umpierrez, G. E. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.11.010 · Cited by 80
Self-citationManagement of Glucocorticoid-Induced Hyperglycemia
Shah, P., Kalra, S., Yadav, Y., Deka, N., Lathia, T., Jacob, J. J., Kota, S. K., Bhattacharya, S., Gadve, S. S., Subramanium, K., et al. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s330253 · Cited by 80
“Baseline Assessment and Evaluation Upon admission, the patient’s family history, concomitant medication, and clinical status, including illness severity, changes in the trajectory of glucose measures, concomitant medications, nutritional status, which could affect glucose levels, should be noted and included in day-to…”
BackgroundMethodResultInfluentialSafety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients
Garg, R., Schuman, B., Hurwitz, S., Metzger, C., & Bhandari, S. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000394 · Cited by 79
Munoz, M., Pronovost, P., Dintzis, J., Kemmerer, T., Wang, N.-Y., Chang, Y.-T., Efird, L., Berenholtz, S. M., & Golden, S. H. (2012) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(12)38025-2 · Cited by 73
“Pocket Cards—We have developed pocket cards to assist providers to act in accordance with recommended glucose management practices through provision of stepwise, algorithmic approaches to (1) insulin initiation and dose titration, (2) transitioning patients from intravenous (IV) to sub-Q insulin, (3) managing acute se…”
BackgroundMethodInfluentialThe clinical impact of inpatient hypoglycemia
Brutsaert, E. F., Carey, M., & Zonszein, J. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.002 · Cited by 78
Perioperative management of diabetes: Translating evidence into practice
Meneghini, L. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76.s4.09 · Cited by 78
Golden, S. H., Maruthur, N., Mathioudakis, N., Spanakis, E., Rubin, D., Zilbermint, M., & Hill-Briggs, F. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0875-2 · Cited by 63
Karunakar, M. A., & Staples, K. S. (2010) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0b013e3181d7aba5 · Cited by 75
Role of Diabetes in the Development of Acute Respiratory Distress Syndrome*
Yu, S., Christiani, D. C., Thompson, B., Bajwa, E. K., & Gong, M. N. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e318298a2eb · Cited by 76
Coronary Artery Disease and Diabetes Mellitus
Aronson, D., & Edelman, E. R. (2015) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.010 · Cited by 74
II Diretriz de Avaliação Perioperatória da Sociedade Brasileira de Cardiologia
Feitosa, A. C. R., Marques, A. C., Caramelli, B., Ferreira, B. M. A., Polanczyk, C. A., Jardim, C., Vieira, C. L. Z., Pinho, C., Calderaro, D., Gualandro, D. M., et al. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011000800001 · Cited by 73
Marvin, M. R., Inzucchi, S. E., & Besterman, B. J. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0277 · Cited by 73
Self-citationWagner, A., Cohen, N., Kelder, T., Amit, U., Liebman, E., Steinberg, D. M., Radonjic, M., & Ruppin, E. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145486 · Cited by 61
The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes
Amod, A. (2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872276 · Cited by 76
Perioperative glycemic management in adults presenting for elective cardiac and non-cardiac surgery
Sreedharan, R., Khanna, S. K., & Shaw, A. (2023) · Perioperative Medicine · doi:10.1186/s13741-023-00302-6 · Cited by 70
Prediction and Prevention of Treatment-Related Inpatient Hypoglycemia
Elliott, M. B., Schafers, S. J., McGill, J. B., & Tobin, G. S. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600213 · Cited by 61
Leite, S. A. O., Locatelli, S. B., Niece, S. P., Oliveira, A. R., Tockus, D., & Tosin, T. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-49 · Cited by 70
Glucose Control, Diabetes Status, and Mortality in Critically Ill Patients
Krinsley, J. S., Maurer, P., Holewinski, S., Hayes, R. L., McComsey, D., Umpierrez, G. E., & Nasraway, S. A. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.04.015 · Cited by 70
Self-citationNear-Continuous Glucose Monitoring Makes Glycemic Control Safer in ICU Patients*
Preiser, J.-C., Lheureux, O., Thooft, A., Brimioulle, S., Goldstein, J., & Vincent, J.-L. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003157 · Cited by 67
Khodakarami, R., Abdi, Z., Ahmadnezhad, E., Sheidaei, A., & Asadi‐Lari, M. (2022) · BMC Public Health · doi:10.1186/s12889-022-13627-6 · Cited by 69
The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes (Revised)
(2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872287 · Cited by 69
Management of hyperglycemia in hospitalized patients
Smiley, D., & Umpierrez, G. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05805.x · Cited by 64
Self-citationRichards, J. E., Hutchinson, J. R., Mukherjee, K., Jahangir, A. A., Mir, H. R., Evans, J. M., Perdue, A. M., Obremskey, W. T., Sethi, M. K., & May, A. K. (2014) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000177 · Cited by 68
“Even consensus statements provide few general recommendations for glucose management in this surgical population.(29) It is also important to consider that many factors are involved in the development of infectious complications, and additional variables or even yet undefined factors that influence SSI that were not c…”
Inpatient Management of Diabetes and Hyperglycemia
Bogun, M. M., & Inzucchi, S. E. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.04.008 · Cited by 67
Self-citationGornik, I., Brajković, A. V., Renar, I. P., & Gašparović, V. (2010) · Critical Care · doi:10.1186/cc9101 · Cited by 67
Sanz‐París, A., Hernández, J. Á., Ballesteros-Pomar, M. D., Romero, F. B., León-Sanz, M., Martín-Palmero, Á., Olmos, M. Á. M., & Olveira, G. (2017) · Nutrition · doi:10.1016/j.nut.2017.02.014 · Cited by 68
Inpatient Diabetes Education in the Real World: an Overview of Guidelines and Delivery Models
Nassar, C. M., Montero, A. R., & Magee, M. F. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1222-6 · Cited by 67
Calleja, A. I., García-Bermejo, P., Cortijo, E., Bustamante, R., Martínez, E. R., Sarmiento, E. G., Fernández-Herranz, R., & Arenillas, J. F. (2011) · Diabetes Care · doi:10.2337/dc11-1242 · Cited by 67
13. Diabetes Care in the Hospital, Nursing Home, and Skilled Nursing Facility
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s016 · Cited by 67
Hiperglucemia de estrés y su control con insulina en el paciente crítico: evidencia actual
Manzanares, W., & Aramendi, I. (2009) · Medicina Intensiva · doi:10.1016/j.medin.2009.10.003 · Cited by 66
Seisa, M. O., Saadi, S., Nayfeh, T., Muthusamy, K., Shah, S. H., Firwana, M., Hasan, B., Jawaid, T., Abd-Rabu, R., Korytkowski, M. T., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac277 · Cited by 65
Self-citationRSSDI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2022
(2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01129-5 · Cited by 66
Buehler, L., Fayfman, M., Alexopoulos, A.-S., Zhao, L., Farrokhi, F., Weaver, J., Smiley-Byrd, D., Pasquel, F. J., Vellanki, P., & Umpierrez, G. E. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.07.027 · Cited by 59
“Several retrospective and randomized controlled trials in cardio-surgical, ICU (Abdelmalak et al., 2014; American Medical Association, 2013; Bagshaw et al., 2010; Baker et al., 2006; Bardou et al., 2013; Flegal et al., 2007; Frisch & Smiley, 2010; Haslam & James, 2005; Hutagalung et al., 2011; Kluczynski et al., 2014;…”
BackgroundInfluentialSelf-citationPrognostic Factors in Pediatric Sepsis Study, From the Spanish Society of Pediatric Intensive Care
Pérez, D. V., Jordán, I., Esteban, E., García-Soler, P., Murga, V., Bonil, V., Ortiz, I., Flores, C., Bustinza, A., & Lasaosa, F. J. C. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000435502.36996.72 · Cited by 65
Jeon, C. Y., Furuya, E. Y., Berman, M. F., & Larson, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045616 · Cited by 64
“We classified the blood glucose levels into six categories: ,80, 80–109, 110–139, 140–179, and $180 mg/dL based on recommended glucose targets from published guidelines for glucose control in inpatients or patients undergoing surgery [11,12,13,14,15].”
BackgroundMethodHsia, E., Seggelke, S. A., Gibbs, J., Rasouli, N., & Draznin, B. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533611420727 · Cited by 62
Hinzmann, R., Schlaeger, C., & Tran, C. T. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.4520 · Cited by 64
KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD
Mottl, A. K., Alicic, R. Z., Argyropoulos, C., Brosius, F. C., Mauer, M. S., Molitch, M. E., Nelson, R. G., Perreault, L., & Nicholas, S. B. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.09.010 · Cited by 62
Glucose control positively influences patient outcome: A retrospective study
Penning, S., Pretty, C. G., Preiser, J., Shaw, G. M., Desaive, T., & Chase, J. G. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.12.013 · Cited by 61
Glucagon orchestrates stress‐induced hyperglycaemia
Harp, J. B., Yancopoulos, G. D., & Gromada, J. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12668 · Cited by 61
“Of greater concern is that in clinical practice, hypoglycaemia rates have been reported of up to 20% in ICU patients with SIH [58].”
BackgroundInfluentialDoumouras, A. G., Lee, Y., Paterson, J. M., Gerstein, H. C., Shah, B. R., Sivapathasundaram, B., Tarride, J.-E., Anvari, M., & Hong, D. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.6820 · Cited by 55
Pasquel, F. J., Fayfman, M., & Umpierrez, G. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1184-8 · Cited by 61
Self-citationDonsa, K., Spat, S., Beck, P., Pieber, T. R., & Holzinger, A. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-16226-3_10 · Cited by 60
“Furthermore, a recent diabetes guideline emphasizes the use of CCDSS and CPOE for insulin dosing [75].”
BackgroundPerioperative management of endocrine insufficiency after total pancreatectomy for neoplasia
Maker, A. V., Sheikh, R., & Bhagia, V. (2017) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-017-1603-8 · Cited by 60
Zhang, Y., Yin, X., Liu, T., Ji, W., & Wang, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-71778-5 · Cited by 59
“In this subgroup, elevated SHR was significantly associated with an increased risk of death (HR 1.79, 95% CI 1.40–2.29), whereas in the no therapy group, high SHR did not significantly affect mortality risk (HR 0.61, 95% CI 0.24–1.55).”
InfluentialHyperglycemia and Acute Kidney Injury During the Perioperative Period
Mendez, C. E., Mesropian, P. J. D., Mathew, R. O., & Slawski, B. A. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0701-7 · Cited by 59
Perioperative management of ambulatory surgical patients with diabetes mellitus
Vann, M. A. (2009) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3283310f51 · Cited by 58
Effects of intensive glycemic control on outcomes of cardiac surgery
Giakoumidakis, K., Eltheni, R., Patelarou, E., Theologou, S., Patris, V., Michopanou, N., Mikropoulos, T., & Brokalaki, H. (2013) · Heart & Lung · doi:10.1016/j.hrtlng.2012.12.007 · Cited by 58
Chase, J. G., Desaive, T., Bohé, J., Cnop, M., Block, C. E. M. D., Gunst, J., Hovorka, R., Kalfon, P., Krinsley, J. S., Renard, É., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2110-1 · Cited by 58
Continuous Glucose Monitoring in Insulin-Treated Patients in Non-ICU Settings
Gomez, A. M., & Umpierrez, G. E. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814546025 · Cited by 51
“Even though quality control programs are essential to meeting FDA requirements and to maintaining the accuracy and reliability of BG testing,(16) a 20% variance between BG measurements derived from POC testing and the laboratory value is considered acceptable.(16,21) Recent reports have advocated improvement or tighte…”
BackgroundSelf-citationEffects of Moderate Intensity Glycemic Control After Cardiac Surgery
Leibowitz, G., Raizman, E., Brezis, M., Gläser, B., Raz, I., & Shapira, O. M. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.07.063 · Cited by 57
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Chawla, R., Madhu, S. V., Makkar, B. M., Ghosh, S. K., Saboo, B., Kalra, S., & On behalf of RSSDI-ESI Consensus Group (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00819-2 · Cited by 61
Bueno, E., Benitez, A., Rufinelli, J., Figueredo, R., Alsina, S., Ojeda, A., Samudio, S., Cáceres, M., Argüello, R., Romero, F., et al. (2015) · Endocrine Practice · doi:10.4158/ep15675.or · Cited by 56
Self-citationIs Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?
Umpierrez, G. E., & Korytkowski, M. (2013) · Diabetes Care · doi:10.2337/dc12-2233 · Cited by 49
Self-citationSafe care for people with diabetes in hospital
Dhatariya, K., Mustafa, O. G., & Rayman, G. A. (2020) · Clinical Medicine · doi:10.7861/clinmed.2019-0255 · Cited by 56
Impact of Hypoglycemia in Hospitalized Patients
Carey, M., Boucai, L., & Zonszein, J. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0336-x · Cited by 56
Initial Management of Septic Patients with Hyperglycemia in the Noncritical Care Inpatient Setting
Schüetz, P., Kennedy, M., Lucas, J. M., Howell, M. D., Aird, W. C., Yealy, D. M., & Shapiro, N. I. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.03.001 · Cited by 55
“(standard deviation) age of the cohort was 60 (20) years, and 48% were women.”
Backgroundfor the ProHOSP Study Group, Schüetz, P., Friedli, N., Grolimund, E., Kutz, A., Haubitz, S., Christ‐Crain, M., Thomann, R., Zimmerli, W., Hoess, C., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3112-9 · Cited by 55
“This recommendation is mainly based on several large studies, principally from the critical-care setting, reporting associations of elevated initial blood glucose levels and increased adverse outcome risk in postoperative patients and patients with sepsis [3, 15, 29–32].”
BackgroundVergès, B. L., Avignon, A., Bonnet, F., Catargi, B., Cattan, S., Cosson, E., Ducrocq, G., Elbaz, M., Fredenrich, A., Gourdy, P., et al. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.11.003 · Cited by 55
Perioperative management of adult diabetic patients. Intraoperative period
Cheisson, G., Jacqueminet, S., Cosson, E., Ichaï, C., Leguerrier, A.-M., Catargi, B., Ouattara, A., Tauveron, I., Valensi, P. E., & Benhamou, D. (2018) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2018.02.018 · Cited by 55
Insulin Therapy in Hospitalized Patients
Pérez, A., Ramos, A., & Carreras, G. (2020) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001078 · Cited by 45
Nirantharakumar, K., Chen, Y. F., Marshall, T., Webber, J., & Coleman, J. J. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03540.x · Cited by 50
Pichardo-Lowden, A. R., Fan, C., & Gabbay, R. A. (2010) · Endocrine Practice · doi:10.4158/ep10220.ra · Cited by 55
Qureshi, A. I., Huang, W., Lobanova, I., Chandrasekaran, P. N., Hanley, D. F., Hsu, C. Y., Martin, R. H., Steiner, T., Suárez, J. I., Yamamoto, H., et al. (2021) · Stroke · doi:10.1161/strokeaha.121.034928 · Cited by 54
Transition From Intravenous to Subcutaneous Insulin
Avanzini, F., Marelli, G., Donzelli, W., Busi, G., Carbone, S., Bellato, L., Colombo, E. L., Foschi, R., Riva, E., Roncaglioni, M. C., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2023 · Cited by 50
Pathophysiology and Management of Hypoglycemiain End-Stage Renal Disease Patients: A Review
Gianchandani, R. Y., Neupane, S., Iyengar, J. J., & Heung, M. (2016) · Endocrine Practice · doi:10.4158/ep161471.ra · Cited by 54
Jehan, F., Khan, M., Sakran, J. V., Khreiss, M. R., O’Keeffe, T., Chi, A., Kulvatunyou, N., Jain, A., Zakaria, E. R., & Joseph, B. A. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001724 · Cited by 54
Mohan, S., Kaoutzanis, C., Welch, K. B., Vandewarker, J. F., Winter, S. M., Krapohl, G. L., Lampman, R. M., Franz, M., & Cleary, R. K. (2015) · International Journal of Colorectal Disease · doi:10.1007/s00384-015-2322-7 · Cited by 54
Kosiborod, M., Gottlieb, R. K., Sekella, J. A., Peterman, D., Grodzinsky, A., Kennedy, P., & Borkon, M. A. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000037 · Cited by 47
Mazloom, Z., Abdollahzadeh, S. M., Dabbaghmanesh, M. H., & Rezaianzadeh, A. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 53
Metadata
- Authors
- Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E.
- Affiliations
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Missouri–Kansas City (US)
- University of Washington (US)
- Yale New Haven Hospital (US)
- Department of Medicine, Physiology and Biophysics, Division of Clinical and Molecular Endocrinology, Case Western Reserve University, Cleveland, Ohio;
- American Diabetes Association (US)
- Emory University (US)
- Corresponding author
- Moghissi, Etie S.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-01
- Volume
- 32
- Issue
- 6
- Pages
- 1119-1131
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681039
- OpenAlex
- W2149347361
- Cited by
- 1,444
- References
- 171
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 78 · 2023: 63 · 2022: 66 · 2021: 83 · 2020: 98 · 2019: 67 · 2018: 84 · 2017: 85 · 2016: 101 · 2015: 105 · 2014: 134 · 2013: 89 · 2012: 131
- FWCI
- 76.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- inpatient glycemic control, hyperglycemia, stress hyperglycemia, intensive insulin therapy, hypoglycemia, critically ill patients, hospitalized patients, transition to outpatient care, cost-effectiveness, glucose monitoring, clinical outcomes
- MeSH terms
- Blood Glucose, Consensus Statements as Topic, Diabetes Mellitus, Endocrinology, Humans, Hyperglycemia, Inpatients, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.